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Abstract
Respiratory syncytial virus (RSV) is the leading cause of hospitalization especially in young children with respiratory tract
infections (RTI). Patterns of circulating RSV genotypes can provide a better understanding of the molecular epidemiology of
RSV infection. We retrospectively analyzed the genetic diversity of RSV infection in hospitalized children with acute RTI
admitted to University Hospital Heidelberg/Germany between October 2012 and April 2013. Nasopharyngeal aspirates
(NPA) were routinely obtained in 240 children younger than 2 years of age who presented with clinical symptoms of upper
or lower RTI. We analyzed NPAs via PCR and sequence analysis of the second variable region of the RSV G gene coding for
the attachment glycoprotein. We obtained medical records reviewing routine clinical data. RSV was detected in 134/240
children. In RSV-positive patients the most common diagnosis was bronchitis/bronchiolitis (75.4%). The mean duration of
hospitalization was longer in RSV-positive compared to RSV-negative patients (3.5 vs. 5.1 days; p,0.01). RSV-A was detected
in 82.1%, RSV-B in 17.9% of all samples. Phylogenetic analysis of 112 isolates revealed that the majority of RSV-A strains
(65%) belonged to the novel ON1 genotype containing a 72-nucleotide duplication. However, genotype ON1 was not
associated with a more severe course of illness when taking basic clinical/laboratory parameters into account. Molecular
characterization of RSV confirms the co-circulation of multiple genotypes of subtype RSV-A and RSV-B. The duplication in
the G gene of genotype ON1 might have an effect on the rapid spread of this emerging RSV strain.
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Introduction
Respiratory syncytial virus (RSV) is the major pathogen of lower
respiratory tract infections (RTI) in infants and young children. By
the age of 2 years, virtually all children have been infected at least
once with RSV [1]. Re-infections are common throughout life; in
older children and adults infections are associated with milder
disease indicating that RSV induces only partial immunity [2].
Strain variation is thought to contribute to its ability to cause
frequent re-infections [3] enabling RSV to remain present at high
levels in the population [4]. Viral strains are separated into two
major groups based on its genetic and antigenic variability. Several
lineages within the subtypes RSV-A and RSV-B co-circulate
simultaneously in the population [5] and their relative proportions
may differ between epidemics, although RSV-A viruses tend to
predominate [6]. The main differences between RSV-A and RSV-
B are found in the attachment (G) glycoprotein [7]. The G protein
is a type II surface glycoprotein of about 300 amino acids in
length, consisting of a cytoplasmic domain, a transmembrane
domain and an ectodomain. The G protein is heavily glycosylated
with N-linked and O-linked sugars. However, the amino acid
sequence positions of potential glycosylation sites are poorly
conserved [8].
This protein is able to accommodate drastic changes with the
emergence of new variants. Diversity occurs mainly in the two
hypervariable regions of the ectodomain which are separated by a
highly conserved 13-amino acid (aa) length domain [9]. Sequenc-
ing of the second hypervariable region at the C-terminal end of the
G gene has been widely used to further subdivide RSV-A and
RSV-B into genotypes and facilitated differentiation between RSV
isolates. To date, 11 RSV-A genotypes, GA1-GA7, SAA1, NA1-
NA2, and ON1 [10–12], and 23 RSV-B genotypes, GB1-GB4,
SAB1-SAB3, SAB4, URU1, URU2, BAI - BAXII, and THB
[10,13–21] have been described based on nucleotide sequence
analysis.
RSV strains show an accumulation of translated amino acid
changes over the years, suggesting antigenic drift-based immunity-
mediated selection [22]. In 1999, a new RSV-B genotype BA
emerged in Buenos Aires, Argentina, containing a 60-nucleotide
(nt) duplication in the second hypervariable region of the G gene
[23]. In the following ten years, the BA genotype spread
worldwide and largely replaced previous described RSV-B
genotypes [24]. During the 2010–11 winter season, a novel
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RSV-A genotype ON1 with a 72-nt duplication has been reported
in Canada [14]. In line with the gradual spread of the BA
genotype making it the dominant circulating RSV-B genotype
today, the nucleotide duplication of the ON1 genotype might
likewise result in a similar selection advantage [25]. There is an
increasing number of reports from across the world describing this
novel genotype and the following seasons will show its impact on
the evolution of RSV-A [6].
In Germany, there is only limited information regarding the
molecular epidemiology of RSV, the emergence of novel viral
strains and their impact on the course of RSV infection. In the
present study, we evaluated hospitalized children below the age of
2 years presenting with acute RTI in the Pediatric Department in
Heidelberg, Germany during the winter season 2012–13. We
investigated the genetic diversity and patterns of the co-circulating
genotypes of Heidelberg RSV-A and RSV-B strains in comparison
with other RSV strains circulating worldwide. Furthermore we
explored a possible association between individual RSV genotypes
and the course of RSV infection by retrospectively analyzing basic
clinical and laboratory data.
Materials and Methods
Patients and clinical samples
We retrospectively analyzed children under the age of 2 years
admitted to the Pediatric Department at the Heidelberg University
Hospital between October 2012 and April 2013 with clinical
symptoms of upper or lower respiratory tract infection (RTI) as
part of their admission diagnosis or as concomitant symptom.
Prior to the transfer to the inpatient unit, nasopharyngeal aspirates
(NPA) are obtained and these children are routinely screened for
RSV infection using a rapid antigen test in order to inform for
isolation strategies. All obtained NPAs (242 samples from 240
children) were collected and stored frozen for further molecular
analysis by RSV PCR and phylogenetic analysis. Medical records
were reviewed from all children to obtain routine clinical and
laboratory data. Patient records were anonymized and de-
identified prior to analysis. The Ethical Committee of the
University of Heidelberg has approved this study (S-166/2014).
PCR and sequencing
For PCR analysis, RNA was extracted from NPAs using the
QIAamp viral RNA mini kit (Qiagen, Hilden, Germany)
according to the manufacturer’s protocol. Amplification and
detection of viral RNA was performed with the RealStar RSV
real-time PCR kit (altona Diagnostics, Hamburg, Germany) on a
LightCycler 480 instrument II (Roche, Mannheim, Germany).
This assay differentiated RSV into subtypes A and B. For
sequencing and identification of RSV genotypes, extracted RNA
was initially reverse transcribed and cDNA was synthesized using
random hexamer primers. Subsequently, PCR targeting the
second hypervariable region of the G gene was performed using
primer pairs as previously described by Peret et al. [11]. PCR
products were sequenced with the same primer pairs previously
used for amplification. Overlapping sequences were assembled
and edited using the SEQMAN II software of the Lasergene
package (DNAstar, Madsion, WI). Nucleotide sequences of the
second hypervariable region of the G gene retrieved in this study
were deposited in GenBank under accession numbers [KJ710364-
KJ710420].
Phylogenetic and deduced amino acid sequence analysis
Multiple sequence alignments and phylogenetic analysis of the
second hypervariable region of the G gene were conducted using
the Clustal W 1.6 method of MEGA software version 6 [26].
Phylogenetic trees were generated using the maximum-likelihood
method and bootstrap values with 1,000 replicates were calculated
to evaluate confidence estimates. Reference strains representing
known genotypes were retrieved from GenBank (http://www.
ncbi.lm.nih.gov) and included in the tree. Pairwise nucleotide
distances were calculated to compare the differences within and
between genotypes of subgroup RSV-A and RSV-B using MEGA
software version 6. Positive selected sites were estimated by use of
the Datamonkey Web server (http://www.datamonkey.org) iden-
tifying the rates of non-synonymous and synonymous substitutions
[27].
Deduced amino acid sequences were translated with the
standard genetic code using MEGA software version 6. Align-
ments of the second hypervariable region of the G protein of
Heidelberg RSV-A and RSV-B strains were compared to
references strains from GenBank to identify amino acid substitu-
tions. Putative N-glycosylation sites were predicted if the encoded
amino acid sequence was Asn-Xaa-Thr/Ser, where Xaa was not a
proline and accepted if the glycosylation potential was $0.5 in
NetNGlyc 1.0 server [28]. O-glycosylation was determined using
the NetOGlyc 3.1 server and sites were predicted using a G-score
$0.5 [29].
Statistical analysis of epidemiological factors
To describe the temporal distribution of admitted RSV cases,
we aggregated RSV results as obtained by PCR by calendar
month and week. Demographic and clinical data in our study
population was summarized. Group comparisons were performed
using x2 or Fisher’s exact test for categorical variables and by
Student’s t-test or analysis of variance (ANOVA) for continuous
variables, as appropriate. P-values ,0.05 were considered
statistically significant. Stata/IC13.0 (StataCorp. LP, College
Station, TX, USA) was used for all statistical analysis.
Results
Detection of RSV
Between October 2012 and April 2013, a total of 242 samples
from hospitalized infants and children were analyzed for RSV
infection by PCR resulting in 134 (55.4%) RSV-positive samples.
Among these RSV-positive samples, 110 (82.1%) were sub-
grouped as RSV-A and 24 (17.9%) as RSV-B, respectively. No
co-infection for RSV-A and RSV-B was detected. Two children
presented twice and were tested RSV-positive at their first
admission and RSV-negative at the consecutive admission few
weeks later. The distribution of RSV-A and RSV-B per calendar
week and month is shown in Fig. 1.
Sequence alignments and phylogenetic analysis
Sequences of the second hypervariable region of the G gene
from 97 (72.4%) RSV-A and 15 (11.2%) RSV-B samples were
successfully obtained and aligned with representative GenBank
sequences of previously published genotypes. Due to a low viral
load some RSV-positive samples (n = 22; 16.4%) could not be
sequenced. The phylogenetic trees of RSV-A and RSV-B
sequences are shown in Figure 2. Heidelberg RSV_A and RSV-
B strains clustered into three genotypes for RSV-A and two
genotypes for RSV-B, respectively.
The majority of RSV-A strains (n = 73, 75.3%) clustered with
strains that were previously assigned to the novel ON1 genotype
with a 72-nt duplication, followed by strains clustering with
genotype NA1 (n = 23, 31.5%) and one strain clustering with GA5
(Fig. 2A). Sequence homology between Heidelberg sequences and
RSV Genotype ON1 in Germany
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the ON1 reference strain [JN257693] was $96.9% at the
nucleotide level and $94.1% at the amino acid level. The
intragenotypic p-distance was 1.9% for ON1 and 6.2% for NA1
for Heidelberg sequences. The intergenotypic p-distance for ON1
and NA1 was not comparable because of the 72-nt duplication.
All RSV-B strains (n = 15) clustered with strains that were
previously assigned to the BA genotype with a 60-nt duplication.
In addition, BA strains could be further differentiated into the
previously designated genotypes BAIX (n = 10, 66.7%) and BAX
(n = 5, 33.3%) (Fig. 2B). Sequence homology between Heidelberg
sequences and the BA reference strain (AY333364) was 94.3%–
96.6% at the nucleotide level and 87%–95% at the amino acid
level. The intergenotypic p-distance for BAIX and BAX was 4.7%
for Heidelberg sequences, with an intragenotypic p-distance of 3%
for BAIX and 0.8% for BAX.
Deduced amino acid sequence analysis
We aligned and compared Heidelberg RSV-A genotype NA1
and GA5 strains with the A2 reference strain (M11486) (Fig. 3A).
The majority of NA1 strains had three predicted N-glycosylation
sites at amino acid (aa) positions 237, 251 and 294. However,
HD12262 had an additional predicted N-glycosylation site at aa
position 242 and HD12188 at aa position 273. A group of 11
isolates lost the N-glycosylation site at aa positions 237 due to a
N237D/H substitution. Strain HD12055 lost all N-glycosylation
site but the aa position 294. The N-glycosylation site at aa position
250 is characteristic for the GA5 genotype as found in one of the
Heidelberg isolates. O-glycosylation patterns varied between
Heidelberg isolates with 3263 sites potentially O-glycosylated
(G-score $0.5) in NA1 isolates and 23 sites in the one GA5 isolate.
As a consequence of the insertion in the G gene, ON1 genotype
strains translate into a polypeptide with a length of 321 amino
acids and are thereby lengthened by 24 aa when compared to the
A2 reference strain (Fig. 3B). The insertion contains a 23 aa
duplicated region. The comparison of Heidelberg ON1 strains
with ON1 strains from other countries with reference to the
original strain from Canada (JN257693) revealed that Heidelberg
isolates can be divided into three sub-clusters: The first sub-cluster
(n = 12) comprises isolates closely related to the primary Canadian
strain (JN257693) with few mixed substitutions. This sub-cluster
also includes one strain with an E308K substitution as previously
described in South African strains [JX885730]. The second sub-
cluster (n = 28) contained three characteristic substitutions, L274P,
L298P and Y304H as previously described in strains from
Wuerzburg, Germany [JX912364, JX12364], as well as in strains
from Italy and Japan [KC858245, KC587959; AB808774,
AB808757]. Furthermore, on group of 13 identical isolates
showed a E287K substitution which was unique for Heidelberg
strains. The third sub-cluster consists of 28 isolates with a L310P
substitution in addition to the three substitutions found in the
second sub-cluster and aligned with isolates from Japan, India and
Kenya [AB808774, AB808757; KF246641, KF246640;
KF587959]. A group of 19 identical strains additionally showed
a V303A substitution, which was also seen in strains from Italy,
Croatia and India [KC858245, KC587959; KF057865;
Figure 1. Weekly/monthly distribution of subgroup RSV A/RSV B in children#2 years with acute RTI in Heidelberg/Germany, winter
season 2012/13.
doi:10.1371/journal.pone.0109191.g001
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Figure 2. Phylogenetic tree of RSV A/RSV B strains and reference sequences of identified genotypes. Phylogenetic trees for RSV A (A)
and RSV B (B) strains were constructed with maximum-likelihood method with 1,000 bootstrap replicates using MEGA 6 software. RSV strains from
Heidelberg/Germany are indicated by ‘‘NHD’’ followed by their strain identification number. Number of identical strains is indicated in brackets after
the strain identifier. Reference strains representing known genotypes were retrieved from GenBank and included in the tree (labels include accession
number). The genotype assignment is shown on the right by brackets. Prototype strains (M11486 for subgroup A and M17213 for subgroup B) were
used as an outgroup. Bootstrap values greater than 70% are indicated at the branch nodes. The scale bar represents the number of nucleotide
substitutions per site. cl. = cluster.
doi:10.1371/journal.pone.0109191.g002
Figure 3. Alignment of deduced amino acid sequences of RSV-A strains. A) Alignment of RSV-A genotype NA1 and GA5 are shown relative
to the sequence of prototype strain A2 (GenBank accession number M11486). Alignment of sequences was performed using the Clustal W 1.6
method via MEGA 6 software. The amino acid positions correspond to positions 210 to 298 of the G protein of strain A2. Identical residues are
indicated by dots, asterisks indicate the position of stop codons. Number of identical strains is indicated in brackets after the strain identifier in the
left column. Gray shading highlights predicted N-glycosylation sites. Unfilled circles indicate predicted O-glycosylation sites of the prototype strain
A2; potential O-glycosylation sites of Heidelberg strains are indicated by black dots. The genotype assignment is shown on the right by brackets. B)
Alignments are shown relative to the sequence of ON1 strain first described in Canada (GenBank accession number JN257693). Alignment of sequences
was performed using the Clustal W 1.6 method via MEGA 6 software. The amino acid positions correspond to positions 210 to 298 of the G protein of the
prototype strain A2. Identical residues are indicated by dots, asterisks indicate the position of stop codons. Boxes frame the 23 amino acid duplicated
region of the 24 amino acid insertion. Gray shading highlights predicted N-glycosylation sites. Unfilled circles indicate predicted O-glycosylation sites of
the Canadian reference ON1 strain; potential O-glycosylation sites of Heidelberg strains are indicated by black dots. On the right hand site, GenBank and
Heidelberg strains are labeled with the country and time of occurrence (month/year).
1 Sequences were published in GenBank only.
HD= Heidelberg; WUE= Wuerzburg, cl. = cluster.
doi:10.1371/journal.pone.0109191.g003
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KF246641, KF246640]. However, positive selection analysis of
ON1 strains revealed no positive selected site.
All Heidelberg ON1 strains had two predicted N-glycosylation
sites at aa positions 237 and 318 and lost the N-glycosylation sites
at aa position 251 due to a T251K substitution. ON1 strains
showed different patterns of O-glycosylation sites with 31 to 44
predicted sites and showed some new sites when compared to the
Ontario reference strain. The 23-aa duplicated region contained a
maximum of 10 glycosylation sites as observed in 17 ON1 isolates
from Heidelberg.
Heidelberg RSV-B genotype BA strains were compared to BA
reference strain from Buenos Aires [AF33364] (Fig. 4). Stop
codons were either at aa position 320 for HD24308, HD24250
and HD24278 or at aa position 313 for the remaining BA strains.
All BA strains had a K218P, L223P and S247P substitution. The
BAIX genotype had a H287Y and a V271A substitution.
Furthermore some BAIX strains (sub-cluster 1) had a P291L
substitution whereas other BAIX strains (sub-cluster 2) had an
I281T substitution. The BAX strains had a P291G substitution.
All Heidelberg RSV B strains had a predicted N-glycosylation
site at aa positions 296. However the N-glycosylation site at aa
position 310 only fulfilled the typical amino acid patterns but the
glycosylation potential calculated by NetOGlyc 3.1 server was
below 0.5 in isolates with a stop codon at aa position 313.
HD24253 had an additional potential N-glycosylation site at aa
position 230. O-glycosylation of BA strains varied between 40 and
47 predicted sites and showed an additional predicted site at aa
position 317 in longer strains with a stop codon at aa position 320.
Basic and clinical characteristics of the study cohort
The mean age of the all screened children was 7.9 months and
ranged in line with the inclusion criteria between 11 days and 23.8
months. RSV-positive patients were significantly younger com-
pared to RSV-negative patients (t-test; p,0.001). The age group
distribution showed that 62.7% RSV-positive children were below
6 months of age. All children had at least a concomitant acute RTI
at time of admission; however, in some patients the main clinical
diagnosis was non-respiratory (total 12.4%, RSV positive 4.5%).
In RSV-positive patients the most common diagnosis was
bronchitis/bronchiolitis (75.4%). The mean duration of hospital-
ization was longer in RSV-positive patients (3.5 vs. 5.1 days; p,
0.01).
We performed a group comparison of the main three genotypes
(RSV-A: ON1 and NA1; RSV-B: BA) using basic and clinical
characteristics of RSV-positive infants and children (Table 1).
There were no risk factors for one of the three groups of genotypes
identified when looking at the demographic characteristics (age,
gender, weight). Furthermore, we could not identify any associ-
ation between a specific genotype and a more severe course of
illness when taking the retrospectively available clinical and
laboratory parameters into account.
Discussion
RSV accounts for a significant burden of acute respiratory tract
infections particularly in infants and young children in need for
hospital care [30]. Patterns of circulating RSV genotypes can
provide a better understanding of the molecular epidemiology of
RSV infection. In our study, we analyzed the genetic diversity and
patterns of co-circulating genotypes of both, subtypes RSV-A and
RSV-B, during the winter season 2012–13 in Heidelberg/
Germany. RSV was detected in 134 out of 242 samples of which
110 (82.1%) were sub-grouped as RSV-A and 24 (17.9%) as RSV-
B, respectively. Phylogenetic analysis revealed that the majority of
RSV-A strains (n = 73, 75.3%) clustered with strains of the novel
ON1 genotype with a 72-nt duplication first described by Eshaghi
et al. in Ontario, Canada in 2010 [14]. In Germany, circulation of
this genotype was reported for the first time in Wuerzburg in
winter 2011–12 [31]. In line with another study in Europe, this
study reports ON1 as the predominant genotype during the RSV
epidemic season 2012–13, suggesting a rapid spread of this
emerging RSV strain [32,33].
Most RSV cases were detected between December 2012 and
April 2013, which is in line with the previously described
seasonality of RSV infection in Germany [30]. However, the core
season with more than half of all RSV-positive cases was from end-
January to mid-March, which can be considered a late pattern of a
RSV epidemic season in Germany [22]. Within our study
population RSV was detectable in 55.4% of hospitalized children
below the age of 2 years emphasizing the need for RSV screening
on admission to assure proper management and to prevent
nosocomial infections [34].
In our cohort, age group analysis revealed that infants below 6
months of age had the highest infection rates, as expected. Primary
RSV infection commonly occurs within the first year of life [13]
Figure 4. Alignment of deduced amino acid sequences of the second variable region of the G protein of RSV-B strains isolated in
Heidelberg/Germany during 2012–2013 winter season. Alignments are shown relative to the sequence of a prototype BA strain (GenBank
accession number AY333364). Alignment of sequences was performed using the Clustal W 1.6 method via MEGA 6 software. The amino acid positions
correspond to positions 210 to 315 of the G protein of the BA strain. Identical residues are indicated by dots, asterisks indicate the position of stop
codons. Number of identical strains is indicated in brackets after the strain identifier in the left column. Boxes frame the 20 amino acid duplication.
Gray shading highlights predicted N-glycosylation sites. Open circles indicate predicted O-glycosylation sites of the prototype BA strain; potential O-
glycosylation sites of Heidelberg strains are indicated by black dots. Genotypes are shown on the right by brackets.
doi:10.1371/journal.pone.0109191.g004
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and the risk of RSV infection decreases with increasing age [22].
The majority of RSV-positive children presented with bronchitis/
bronchiolitis followed by pneumonia and the duration of
hospitalization was significantly longer compared to RSV-negative
patients. However, the median duration of hospital stay of 5 days
in RSV-positive patients in this study was shorter compared to
previous findings of 7 days [30].
Molecular analysis of RSV-positive samples demonstrated that
RSV-A was the predominant subtype which is in line with
previous findings of multiple-season studies from Europe and other
geographical areas [21,22]. Phylogenetic analysis revealed that the
majority of RSV-A strains (n = 73, 75.3%) clustered with strains of
the novel ON1 genotype with a 72-nt duplication. Phylogenetic
analysis of Tsukagoshi et al. estimated that genotype ON1 evolved
from genotype NA1 [35]. Recent estimates place the time of the
ON1 emergence around 2008/09 [36,37].
Over the past three epidemic seasons (2010–2013) the
prevalence of ON1 strains among all circulating strains varied
between the different reports, but there seems to be a trend
towards ON1 as the predominating RSV-A strain. In its first
description in Ontario/Canada, the genotype ON1 accounted for
10% of RSV-positive samples in the season 2010-11 [14]. In the
same season in Thailand, the majority of RSV isolates belonged to
NA1, only few isolates belonged to ON1 [20]. One season later in
2011–12, RSV-A genotype ON1 was reported in different studies
from Asia, Africa and Europe suggesting a worldwide emergence
of the novel RSV-A strain. However, ON1 was only sporadically
detected during that time and some countries like Pakistan did not
report ON1 among circulating genotypes in 2011–12 [34]. A study
from Heidelberg/Germany evaluating the genetic diversity of
RSV in an outbreak in a haematology unit in 2012 also did not
describe any ON1 strains [38]. In a study from Bejing, China, only
one sample from February 2012 out of about 250 sequenced RSV-
positive samples between 2007 and 2012 was characterized as
ON1 genotype [39]. One report from Wuerzburg/Germany,
assigned 10% of the identified strains to genotype ON1 in 2011–
Table 1. Basic and clinical characteristics of RSV positive children by genotype.
RSV A* RSV B
RSV positive ON1 NA1 BA p-value
n=134 n=73 n=23 n=15
Demographic characteristics
Age in months, mean 6SD 6.566.2 6.466.2 5.765.6 4.865.1 0.63
Age group, n (%)
0–6 months 84 (62.7) 48 (65.8) 15 (65.2) 10 (66.7) 0.18
.6–12 months 20 (14.9) 7 (9.6) 6 (26.1) 3 (20.0)
.12–18 months 20 (14.9) 13(17.8) 0 (0.0) 2 (13.3)
.18–24 months 10 (7.5) 15 (6.9) 2 (8.7) 0 (0.0)
Gender, n (%)
Male 83 (61.9) 44 (60.3) 18 (78.3) 9 (60.0) 0.28
Female 51 (38.1) 29 (39.7) 5 (21.7) 6 (40.0)
Weight in kg, mean 6SD 6.262.3 5.962.1 7.062.7 5.862.3 0.11
Leading clinical diagnosis, n (%)
Non-respiratory 6 (4.5) 4 (5.5) 0 (0.0) 1 (6.7) 0.49
Respiratory 128 (95.5) 69 (94.5) 23 (100.0) 14 (93.3)
Upper RTI 4 (3.0) 1 (1.4) 1 (4.4) 0 (0.0) 0.61
Bronchitis/Bronchiolitis 101 (75.4) 54 (74.0) 20 (87.0) 12 (80.0)
Pneumonia 23 (17.2) 14 (19.2) 2 (8.7) 2 (6.7)
Course of disease
Symptoms prior to hospitalization in days, mean 6SD 4.263.6 3.963.1 3.962.9 3.865.0 0.98
Hospital stay in days, mean 6SD# 5.363.9 5.363.8 5.562.8 4.562.1 0.68
Need for intensive care, n (%) 6 (4.5) 4 (5.5) 0 (0.0) 1 (6.7) 0.49
Laboratory parameters on admission
Hemoglobin in g/dl, mean 6SD 11.761.7 11.461.5 11.961.9 11.762.0 0.45
Leucocytes/nl, mean 6SD 11.564.7 11.064.5 10.163.6 10.463.8 0.64
Thrombocytes/nl, mean 6SD 434.26120.5 435.86130.9 391.5684.6 467.96117.4 0.17
C-reactive protein in mg/L, mean 6SD 22.5637.0 20.1626.7 22.4624.5 17.5617.7 0.88
pCO2 in mmHg, mean 6SD 41.568.8 41.669.4 42.168.4 45.668.9 0.44
*RSV A genotype GA5 was not included in this table as this genotype was only present in one patient. In total, 112 of 134 RSV positive patients could be sequenced and
a genotype could be determined.
#Hospital stay was only calculated for patients who stayed at least 24 hours in hospital.
SD = standard deviation; RTI = respiratory tract infection, RSV= Respiratory Syncytial Virus.
doi:10.1371/journal.pone.0109191.t001
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12 [31]. In the past months an increasing number of reports about
circulating genotypes in the season 2012–13 were published. In
line with the findings in this study, reports from Cyprus, Italy,
Kenya and South Korea described ON1 as the predominating
genotype in the epidemic season 2012–13 [32,33,36,37]. Our
study therefore describes a further cohort in Europe with ON1 as
the predominating genotype in 2012–13 suggesting a rapid
emergence of this novel strain. Further surveillance of circulating
genotypes will be needed to observe the future global distribution
of the ON1 strain and its trend to diversify.
The comparison of Heidelberg ON1 strains with ON1 strains
from other countries revealed that Heidelberg isolates could be
divided into three sub-clusters with characteristic substitutions as
previously described in different countries and continents. Similar
to the subdivision of RSV-B genotype BA into several sub-
genotypes (BA-I – BAXII), this could be a first trend to a
diversification of the ON1 genotype. However, none of the sub-
clusters had bootstrap values $70%. Furthermore, positive
selection analysis did not reveal any positively selective sites
among ON1 isolates. This is also reflected by two groups of
identical isolates (n = 13 and n = 18) of the ON1 genotype,
suggesting the absence of selective pressure among the newly
emerging strains.
Although the majority of strains was subtyped as RSV-A, 13.4%
of all Heidelberg trains were subtyped as RSV-B. All RSV-B
strains clustered with strains of the BA genotype with a 60-nt
duplication, first described by Trento et al. in Buenos Aires,
Argentina in 1999 [23], further differentiating into the genotypes
BAIX (n = 10, 66.7%) and BAX (n = 5, 33.3%). Genotype BAIX
separated into two sub-clusters: one including the BAIX reference
sequence from Japan designated by Dapat et al. [18] who first
described this genotype in 2007, and the second including the
BAIX reference sequence from India described by Choudhary
et al. in 2010 [40]. However, none of the two sub-clusters had
bootstrap values $70%.
Similar to genotype BA, the nucleotide duplication of the ON1
genotype seems to result in a selection advantage compared to
other RSV-A genotypes. Interestingly, despite the emergence of
the ON1 virus there is conflicting data concerning the virulence in
terms of disease severity [31–33]. In our cohort, retrospective
analysis of basic clinical and laboratory parameters such as the
duration of hospital stay, the need for intensive care as well as
pCO2 levels on admission did not reveal any association between a
specific genotype and disease severity. Further surveillance of
circulating RSV genotypes and corresponding clinical data is
needed to understand the evolution, transmission and pathoge-
nicity of genotype ON1 RSV infections.
Our study is subject to several limitations: We report the genetic
diversity of RSV during one season in winter 2012–13 and a
comparison of proportions of circulating genotypes is therefore
restricted to other reports from Germany as well as worldwide.
Our analysis included hospitalized children with community
acquired RSV infection and therefore cannot draw conclusions
for the overall population of community acquired RSV infections.
However, the cohort of hospitalized children is of particular
clinical relevance. Due to the retrospective study design, the
evaluation of the association between pathogenicity of RSV
infection and genotypes was limited to the available data.
Furthermore, we did not include an analysis of further co-
infections, which might also have an effect on disease severity in
the evaluated study cohort. Further surveillance of the molecular
epidemiology for several seasons in combination with prospec-
tively complied clinical data is needed to directly compare the
emergence of new variants and their transmissibility and virulence.
In summary, molecular characterization of RSV in Heidelberg,
Germany during winter season 2012–13 confirmed the co-
circulation of multiple genotypes of subtype RSV-A and RSV-B
and the predominance of the novel genotype ON1. In line with the
emergence of the BA genotype, it can be hypothesized that
genotype ON1 could spread in a similar way and several branches
might subdivide into further sub-genotypes. However, we could
not find any association between disease severity and this newly
emerging RSV-A genotype ON1. Continuing and long-term
molecular epidemiological surveys for early detection of circulating
and newly emerging genotypes in combination with clinical data
are necessary to gain a better understanding of underlying genetic
and antigenic mechanisms of RSV infection.
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